Skip to content

Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses

Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05886907
Enrollment
18
Registered
2023-06-02
Start date
2023-06-14
Completion date
2023-07-17
Last updated
2024-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Errors, Presbyopia, Astigmatism

Keywords

Contact Lenses

Brief summary

The purpose of this clinical trial is to assess on-eye performance and overall fit of an investigational multifocal toric contact lens to aid in confirmation of the study lens design.

Detailed description

Subjects will attend 3 study visits with a planned individual duration of participation of up to 10 days.

Interventions

DEVICELehfilcon A multifocal toric contact lenses

Investigational silicone hydrogel contact lenses

DEVICESamfilcon A multifocal toric contact lenses

Commercially available silicone hydrogel contact lenses

Hydrogen peroxide based contact lens cleaning and disinfecting solution

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Subjects will wear the products (test and comparator) in a predetermined order.

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Requires ADD (additional power for near vision); * Currently wears multifocal soft contact lenses in both eyes during the past 3 months; * Manifest cylinder power between -0.75 diopter (D) and -1.00 D; * Best Corrected Visual Acuity (BCVA) of logMAR 0.10 (Snellen 20/25) or better in each eye. * Other protocol-specified inclusion criteria may apply. Key

Exclusion criteria

* Any anterior segment infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the Investigator; * Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator; * Current or history of pathologically dry eye in either eye that, in the opinion of the Investigator, would preclude contact lens wear; * Monovision contact lens wear. * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
Mean Distance Visual Acuity (VA) With Study LensesDay 2, each wear period. A wear period was approximately 2 days.Visual Acuity (VA) was assessed binocularly (both eyes together) with study lenses in place at a distance of 4 meters using letter charts. VA was recorded in logarithm minimum angle of resolution (logMAR), where 0.0 logMAR equates to 20/20 Snellen (normal distance eyesight). A lower number indicates better visual acuity. No hypothesis testing is pre-specified for this endpoint.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 1 investigative site located in the United States.

Pre-assignment details

Of the 18 enrolled, 9 were exited prior to study lens assignment as screen failures. This reporting group includes all participants exposed to any study lenses evaluated in this study (9).

Participants by arm

ArmCount
LID223188, Then Ultra MFT
Lehfilcon A multifocal toric contact lenses worn first, with samfilcon A multifocal toric contact lenses worn second. Each product was worn bilaterally (in both eyes) during waking hours for approximately 2 days. CLEAR CARE was used for daily contact lens cleaning and disinfection.
5
Ultra MFT, Then LID223188
Samfilcon A multifocal toric contact lenses worn first, with lehfilcon A multifocal toric contact lenses worn second. Each product was worn bilaterally (in both eyes) during waking hours for approximately 2 days. CLEAR CARE was used for daily contact lens cleaning and disinfection.
4
Total9

Baseline characteristics

CharacteristicLID223188, Then Ultra MFTUltra MFT, Then LID223188Total
Age, Continuous58.6 years
STANDARD_DEVIATION 10
65.0 years
STANDARD_DEVIATION 3.2
61.4 years
STANDARD_DEVIATION 8
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Asian
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Black or African American
3 Participants0 Participants3 Participants
Race/Ethnicity, Customized
Hispanic or Latino
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
4 Participants4 Participants8 Participants
Race/Ethnicity, Customized
Other
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
White
1 Participants4 Participants5 Participants
Sex: Female, Male
Female
2 Participants1 Participants3 Participants
Sex: Female, Male
Male
3 Participants3 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 90 / 180 / 90 / 180 / 9
other
Total, other adverse events
0 / 90 / 180 / 90 / 180 / 9
serious
Total, serious adverse events
0 / 90 / 180 / 90 / 180 / 9

Outcome results

Primary

Mean Distance Visual Acuity (VA) With Study Lenses

Visual Acuity (VA) was assessed binocularly (both eyes together) with study lenses in place at a distance of 4 meters using letter charts. VA was recorded in logarithm minimum angle of resolution (logMAR), where 0.0 logMAR equates to 20/20 Snellen (normal distance eyesight). A lower number indicates better visual acuity. No hypothesis testing is pre-specified for this endpoint.

Time frame: Day 2, each wear period. A wear period was approximately 2 days.

Population: This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study.

ArmMeasureValue (MEAN)Dispersion
LID223188Mean Distance Visual Acuity (VA) With Study Lenses-0.04 logMARStandard Deviation 0.09
Ultra MFTMean Distance Visual Acuity (VA) With Study Lenses-0.09 logMARStandard Deviation 0.07

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026